Palau Pharma S.L.
- Address
- Avinguda Del Cami Reial 51-57
Sponsor Overview
Specializations
Infectious Diseases
Palau Pharma S.L. is involved in clinical research focused on fungal infections, with activity centred on acute vulvovaginal candidiasis and acute Candida vulvovaginitis. Its trial portfolio reflects interest in therapies for symptomatic candidal infection affecting the female genital tract.
- Vulvovaginal candidiasis
- Candida vulvovaginitis
- Antifungal treatment
The sponsor's research activity is concentrated on clinical options for managing localized yeast infection and related gynecological infectious disease.
Women's Health
The sponsored research addresses conditions within gynaecology, particularly infections that cause discomfort, discharge, and irritation in women. The therapeutic focus lies in treatment areas relevant to reproductive tract health and intimate care.
- Gynaecological infection
- Female reproductive health
- Genital tract symptoms
Clinical interest in this area supports evaluation of therapies intended for symptomatic relief and infection clearance in women.
Antifungal Therapeutics
Palau Pharma S.L. explores antifungal drug development through research on albaconazole in comparison with established treatment and placebo. The therapeutic domain includes agents aimed at treating yeast-associated mucosal infection.
- Azole antifungals
- Albaconazole
- Comparative antifungal therapy
This area of interest is aligned with the development of medicines for localized mycotic disease in outpatient settings.
Clinical Pharmacology
The trial activity includes assessment of efficacy, safety, and pharmacokinetics for an oral antifungal candidate. This places emphasis on the clinical behaviour of treatment options used for uncomplicated fungal infection.
- Drug efficacy
- Safety evaluation
- Pharmacokinetic profiling
Research in this domain supports understanding of how antifungal agents perform in human infection management.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy, Safety, and Pharmacokinetics of Single-Dose Albaconazole Versus Fluconazole and Placebo in Acute Vulvovaginal Candidiasis |  Poland Spain | Not Recruiting |
Data & Insights
This sponsor works with 3 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 21 sites across their trial portfolio.
Therapeutic Focus
- 1.Bacterial Infections and Mycoses1 trial180 other sponsors
Partnered Research Centres
21 centres- Address
- Ul. Podpromie 8/1a, 35-051 Rzeszów
- Address
- Calle De Antonio Acuna 9, 28009 Madrid
- Address
- Carretera Santa Creu De Calafell 100, 08850 Gava
- Address
- Placa Del Pla Del Mestre 7, 08540 Centelles
- Address
- Ul. Walerego Eliasza Radzikowskiego 47b/6, 31-315 Krakow
- Address
- Ul. Tadeusza Kosciuszki 229, 40-600 Katowice
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Palau Pharma S.L..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.